Maria Elisabet Wrethag
Director/Board Member at Archaea Pharma AB
Profile
Ms. Maria Elisabet Wrethag is Chief Marketing Officer & Head-Investor Relations at SyntheticMR AB.
She is on the Board of Directors at Accelerator Nordic AB and Archaea Pharma AB.
Ms. Wrethag also served on the board at SPAGO Nanomedical AB and AddBIO AB.
She received her undergraduate degree from the University of Uppsala and a graduate degree from the University of Uppsala.
Maria Elisabet Wrethag active positions
| Companies | Position | Start |
|---|---|---|
| Archaea Pharma AB | Director/Board Member | - |
Former positions of Maria Elisabet Wrethag
| Companies | Position | End |
|---|---|---|
| SPAGO NANOMEDICAL AB | Director/Board Member | - |
AddBIO AB
 AddBIO AB BiotechnologyHealth Technology AddBIO AB provides bone implant technology solutions. It offers Zolidd, a bioactive nanolayer with a bone strengthening drug. The firm's Zolidd is used in the areas of dental and trauma implants. It also offers Zolidiser, a machine to add bone-strengthening drugs to implants. The company was founded by Per Aspenberg and Trine Vikinge in 2008 and is headquartered in Linköping, Sweden. | Director/Board Member | - |
| SYNTHETICMR AB | Director/Board Member | 01/10/2013 |
Accelerator Nordic AB
 Accelerator Nordic AB Pharmaceuticals: MajorHealth Technology Accelator Nordic AB, a holding company, is engaged in the field of life science. It focuses on the development of image software and medical nanotechnology. It operates through its subsidiaries SPAGO Imaging AB, Synthethic MR AB, and PledPharma. The company was founded in March 1993 and is headquartered in Stockholm, Sweden. | Chief Executive Officer | - |
Training of Maria Elisabet Wrethag
| University of Uppsala | Graduate Degree |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| SYNTHETICMR AB | Health Technology |
| SPAGO NANOMEDICAL AB | Health Technology |
| Private companies | 3 |
|---|---|
Accelerator Nordic AB
Accelerator Nordic AB Pharmaceuticals: MajorHealth Technology Accelator Nordic AB, a holding company, is engaged in the field of life science. It focuses on the development of image software and medical nanotechnology. It operates through its subsidiaries SPAGO Imaging AB, Synthethic MR AB, and PledPharma. The company was founded in March 1993 and is headquartered in Stockholm, Sweden. | Health Technology |
AddBIO AB
AddBIO AB BiotechnologyHealth Technology AddBIO AB provides bone implant technology solutions. It offers Zolidd, a bioactive nanolayer with a bone strengthening drug. The firm's Zolidd is used in the areas of dental and trauma implants. It also offers Zolidiser, a machine to add bone-strengthening drugs to implants. The company was founded by Per Aspenberg and Trine Vikinge in 2008 and is headquartered in Linköping, Sweden. | Health Technology |
| Archaea Pharma AB |
- Stock Market
- Insiders
- Maria Elisabet Wrethag
